Frank Fazio

Frank Fazio is a strategic executive with over 30 years of multifaceted experience in the healthy aging, medical device, biotechnology, and pharmaceutical industries. Mr. Fazio has broad experience with early and late-stage clinical development programs including acquisition management, capital fundraising and successful transition to global commercialization. Mr. Fazio has raised more than $75M in private capital for small companies. Additionally, he held several key positions at INAMED Corporation and was extensively involved during the company’s integration to Allergan, Inc. (NASDAQ:AGN) following its $3.2B acquisition of the company. Most notably, Mr. Fazio served as a core team member on the Juvéderm® (hyaluronic acid dermal filler) and Dysport® (neuromodulator) global development programs. Mr. Fazio received his Bachelor of Science Degree in Molecular and Cellular Biology from the University of Arizona.